References
- Tisone G, Manzia TM, Angelico R et al. HCV recurrence and immunosuppression-free state after liver transplantation. Expert Rev. Clin. Immunol. 8(7), 635–644 (2012).
- Orlando G. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Expert Rev. Clin. Immunol. 6(6), 879–892 (2010).
- Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J. Hepatol. 50(6), 1247–1257 (2009).
- Orlando G, Manzia T, Baiocchi L et al. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl. Immunol. 20, 43–47 (2008).
- Tisone G, Orlando G, Cardillo A et al. Complete weaning off immunosuppression reduces the progression rate of fibrosis in HCV liver transplant patients with recurrence of disease: mid-term results. J. Hepatol. 44, 702–709 (2006).
- Brandacher J, Lee WPA, Schneeberger S. Minimizing immunosuppression in hand transplantation. Expert Rev. Clin. Immunol. 8(7), 673–684 (2012)
- Mohanakumar T, Subramanian V. Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens. Expert Rev. Clin. Immunol. 8(7), 635–672 (2012).
- Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Rev. Clin. Immunol. 8(7), 645–661 (2012).
- Ekser B, Burlak C, Waldman JP et al. Immunobiology of liver xenotransplantation. Expert Rev. Clin. Immunol. 8(7), 621–634 (2012).
- Lerut J. Minimalization of immunosuppression in liver transplantation: steps from ‘how’ to ‘now’. Expert Rev. Clin. Immunol. 8(7), 605–607 (2012).
- Pareta R, Sanders B, Babbar P et al. Immunoisolation: where regenerative medicine meets solid organ transplantation. Expert Rev. Clin. Immunol. 8(7), 685–692 (2012).
- Orlando G, García-Arrarás JE, Soker T et al. Regeneration and bioengineering of the gastrointestinal tract: current status and future perspectives. Dig. Liver Dis. (2012).
- Orlando G, Bendala JD, Shupe T et al. Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut (2012) doi: 10.1136/gutjnl-2011-301111 (Epub ahead of print).
- Orlando G, Wood KJ, De Coppi P et al. Regenerative medicine as applied to general surgery. Ann. Surg. 255(5), 867–880 (2012).
- Orlando G. Immunosuppression-free transplantation reconsidered from a regenerative medicine perspective. Expert Rev. Clin. Immunol. 8(2), 179–187 (2012).
- Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation 92(8), e36–e8; author reply e39 (2011).
- Orlando G. Transplantation as a subfield of regenerative medicine: an interview by Lauren Constable. Exp. Rev. Clin. Immunol. 7, 137–141 (2011).
- Orlando G, Baptista P, Birchall M et al. Regenerative medicine as applied to solid organ transplantation: current status and future development. Transpl. Int. 24, 223–232 (2011).
Website
- Immune tolerance network. Gradual Withdrawal of Immunosuppression in Patients Receiving a Liver Transplant (AWISH). www.immunetolerance.org/studies/gradual-withdrawal-immunosuppression-patients-receiving-liver-transplant-awish